The treatment of lung cancer gene mutation is mainly targeted therapy, of course, radiotherapy and chemotherapy are also available. Please strictly follow the doctor’s instruction.
If lung cancer patients have gene mutation during genetic testing, it is actually good news that they can undergo targeted therapy to effectively prolong their survival cycle, only that the specific drugs need to be selected in combination with the specific mutated genes, but the overall effect is relatively good, and the side effects are small.
Generally, if it is EGFR gene mutation, you can choose EGFR-TKI drugs such as ositinib and gefitinib for treatment; if it is ALK and ROS1 gene mutation, you need to use targeted drugs such as crizotinib and sertitinib for treatment; and the targeted drugs for BRAF gene mutation are dabrafenib and trametinib.